AltruBio Company

AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune related inflammatory diseases.

Headquarters: Los Altos, California, United States
Last Funding Type: Series A
Last Funding Date: 2021-04-15
Total Funding: $103 000 000
Founded Date: 2000-06-01
Estimated Revenue: $10M to $50M
Industry: Women Cancer Treatment
Funding Status: Early Stage Venture